Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context

Detalhes bibliográficos
Autor(a) principal: Rodrigues,Bárbara Emilly Matos
Data de Publicação: 2019
Outros Autores: Branco,André Barbosa Castelo, Mendes,Igor Barbosa, Koch,Camila Ribeiro, Amaral,Bruno Andrade, Costa,Lindemberg Assunção
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Oftalmologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000100007
Resumo: Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.
id SBO-1_14857bb3177f47ff8a7218e5a790d722
oai_identifier_str oai:scielo:S0034-72802019000100007
network_acronym_str SBO-1
network_name_str Revista Brasileira de Oftalmologia (Online)
repository_id_str
spelling Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life contextMacular degeneration/therapyRetinal neovascularizationVisual acuityMonoclonal antibodies/therapeutic useAbstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.Sociedade Brasileira de Oftalmologia2019-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000100007Revista Brasileira de Oftalmologia v.78 n.1 2019reponame:Revista Brasileira de Oftalmologia (Online)instname:Sociedade Brasileira de Oftalmologia (SBO)instacron:SBO10.5935/0034-7280.20190002info:eu-repo/semantics/openAccessRodrigues,Bárbara Emilly MatosBranco,André Barbosa CasteloMendes,Igor BarbosaKoch,Camila RibeiroAmaral,Bruno AndradeCosta,Lindemberg Assunçãoeng2019-03-15T00:00:00Zoai:scielo:S0034-72802019000100007Revistahttps://rbo.emnuvens.com.br/rbo/indexhttps://old.scielo.br/oai/scielo-oai.phpsob@sboportal.org.br||rbo@sboportal.org.br1982-85510034-7280opendoar:2019-03-15T00:00Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)false
dc.title.none.fl_str_mv Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
title Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
spellingShingle Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
Rodrigues,Bárbara Emilly Matos
Macular degeneration/therapy
Retinal neovascularization
Visual acuity
Monoclonal antibodies/therapeutic use
title_short Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
title_full Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
title_fullStr Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
title_full_unstemmed Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
title_sort Retrospective study to assess the impact of ranibizumab 0.5mg in the visual acuity of patients with macular diseases in a real life context
author Rodrigues,Bárbara Emilly Matos
author_facet Rodrigues,Bárbara Emilly Matos
Branco,André Barbosa Castelo
Mendes,Igor Barbosa
Koch,Camila Ribeiro
Amaral,Bruno Andrade
Costa,Lindemberg Assunção
author_role author
author2 Branco,André Barbosa Castelo
Mendes,Igor Barbosa
Koch,Camila Ribeiro
Amaral,Bruno Andrade
Costa,Lindemberg Assunção
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues,Bárbara Emilly Matos
Branco,André Barbosa Castelo
Mendes,Igor Barbosa
Koch,Camila Ribeiro
Amaral,Bruno Andrade
Costa,Lindemberg Assunção
dc.subject.por.fl_str_mv Macular degeneration/therapy
Retinal neovascularization
Visual acuity
Monoclonal antibodies/therapeutic use
topic Macular degeneration/therapy
Retinal neovascularization
Visual acuity
Monoclonal antibodies/therapeutic use
description Abstract Objective: The primary objective of the study is to evaluate, in a population in the state of Bahia, Brazil, the impact of ranibizumab in best-corrected visual acuity of patients with macular disease and macular edema. Methods: This study did a retrospective and observational assessment visual acuity of the group of patients followed at the Professor Edgard Santos University Hospital and Oftalmodiagnose Eye Hospital in 2011 and 2012 in a real life context. Results: The impact on sample patientes post-treatment demonstrated favorable outcome with an increase in visual acuity of 32%, which means improvement of more than one line in the snellem chart. Conclusion: Improvement in visual acuity of this group was observed from baseline to the end of follow up in a real-life context.
publishDate 2019
dc.date.none.fl_str_mv 2019-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000100007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000100007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/0034-7280.20190002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Oftalmologia
publisher.none.fl_str_mv Sociedade Brasileira de Oftalmologia
dc.source.none.fl_str_mv Revista Brasileira de Oftalmologia v.78 n.1 2019
reponame:Revista Brasileira de Oftalmologia (Online)
instname:Sociedade Brasileira de Oftalmologia (SBO)
instacron:SBO
instname_str Sociedade Brasileira de Oftalmologia (SBO)
instacron_str SBO
institution SBO
reponame_str Revista Brasileira de Oftalmologia (Online)
collection Revista Brasileira de Oftalmologia (Online)
repository.name.fl_str_mv Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)
repository.mail.fl_str_mv sob@sboportal.org.br||rbo@sboportal.org.br
_version_ 1752122338624667648

Registros relacionados